Media Hub
View the latest content of the NASH Summit Boston and other events of the Fibrosis Series
An exclusive FDA presentation by:
Dr Frank A. Anania, Acting Clinical Team Leader, Division of Gastroenterology and Inborn Error Products, FDA
NASH 2019 - Speaker Interview - Resar Cenar
NASH one pager
Who attended in 2019
Global Liver Institute, Donna Cryer
Targeting multiple pathways in NASH - clinical perspectives for combination therapies | Nikolai Naoumov
Molecular MR Imaging of Oxidized Collagen to Monitor Active Fibrogenesis in Preclinical Models of NASH | Bryan Fuchs
Evaluating Progression Towards Industry Standard In Vitro Models of NAFLD/NASH
